Legend Biotech Corporatio...

36.35
-0.29 (-0.79%)
At close: Jan 28, 2025, 3:03 PM

Cashflow (Annual)

Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17
Net Income -518.25M -445.72M -386.21M -307.62M -130.37M -1.62M 9.37M
Depreciation & Amortization 20.45M 18.39M 13.92M 9.93M 5.26M 1.68M 217.00K
Stock-Based Compensation 47.68M 34.34M 20.16M 4.76M 1.27M 704.00K n/a
Other Working Capital 53.04M 118.75M 114.42M 26.07M 54.27M 108.99M 207.40M
Other Non-Cash Items 128.19M 6.65M 187.74M 84.62M -4.36M -6.13M 228.87M
Deferred Income Tax n/a n/a -174.94M 9.22M -7.35M -5.66M n/a
Change in Working Capital -71.34M 186.32M 140.87M -23.92M 52.48M 318.71M -16.50M
Operating Cash Flow -393.28M -200.03M -198.47M -223.00M -83.06M 307.68M -2.38M
Capital Expenditures -22.72M -22.27M -47.11M -49.78M -39.17M -21.02M -887.00K
Acquisitions n/a n/a 3.21M 4.03M -460.00K 20.00K 60.00K
Purchase of Investments -4.86B -654.97M -377.96M -72.68M -390.40M -6.00M n/a
Sales Maturities Of Investments 5.07B 613.61M 230.08M 98.29M 320.85M n/a n/a
Other Investing Acitivies -91.70M -14.71M -3.20M -4.03M 50.52M -75.23M 55.00K
Investing Cash Flow 92.79M -78.34M -194.98M -24.17M -58.65M -102.26M -827.00K
Debt Repayment -3.75M -2.60M -1.42M -2.60M -5.06M -219.00K -32.00K
Common Stock Repurchased n/a n/a n/a n/a n/a n/a n/a
Dividend Paid n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies 211.56M 2.93M 4.64M 159.40M 19.72M 2.72M 3.35M
Financial Cash Flow 791.49M 377.98M 626.66M 618.88M 14.67M 2.50M 3.32M
Net Cash Flow 491.68M 97.09M 233.25M 372.32M -126.80M 208.05M 128.00K
Free Cash Flow -416.00M -222.30M -245.58M -272.78M -122.23M 286.66M -3.26M

Create Price Alert on LEGN

Your price alert will notify you when the stock price is above 36.35.

Add to Watchlist